IL17A and neoplasm: Given the higher promoter activity of the IL17A gene in the presence of the variant allele, we could assume that the A/A-genotype contributes to the maintenance of inflammation and stimulation of angiogenesis in the growing tumor, which would lead to earlier CRC onset.